March 25, 2011

A pill developed by AstraZeneca and Pozen that combines a nonsteroidal anti-inflammatory drug with a proton-pump inhibitor was well-tolerated in patients with osteoarthritis, according to a new study.

March 17, 2011

Anglo-Swedish drug maker AstraZeneca has enrolled the first patient in a late-stage clinical trial for a drug to treat constipation related to use of opioid painkillers, the company said.

March 8, 2011

The Food and Drug Administration has accepted a regulatory approval application for a Type 2 diabetes drug from Bristol-Myers Squibb and AstraZeneca, the two drug makers said Tuesday.

March 2, 2011

The Food and Drug Administration is warning that long-term use of a class of drugs for gastroesophageal reflux disease may decrease levels of magnesium in the body and increase the risk of such side effects as seizures and heart rhythm problems, according to published reports.

February 24, 2011

Generic drug maker Par Pharmaceutical Cos. had sales of $227 million during fourth quarter 2010 and $1 billion for the year as a whole, according to an earnings statement Thursday.

February 23, 2011

The makers behind a popular Type 2 diabetes treatment have included data from two clinical studies in an update to the drug's prescribing information.

January 31, 2011

Nearly half a million people participated in AstraZeneca's prescription savings programs.

January 17, 2011

A new drug application for Anglo-Swedish drug maker AstraZeneca's vandetanib has been extended.

January 11, 2011

The Food and Drug Administration has accepted a regulatory approval application for a drug to treat Type 2 diabetes made by Merck, the drug maker said Tuesday.

January 7, 2011

A new oral treatment for Type 2 diabetes hit the shelves Friday.

December 21, 2010

An Anglo-Swedish drug maker said it is discontinuing further development of a drug that is designed to prevent a respiratory virus that infects the lungs and breathing passages.

December 21, 2010

A judge recently blocked AstraZeneca from attempting to impede the development of generic versions of its popular cholesterol drug, according to published reports.

December 17, 2010

The Food and Drug Administration has turned down AstraZeneca’s regulatory approval application for a drug to treat heart disease, the drug maker said.

December 9, 2010

An investigational treatment for lung cancer made by Boehringer Ingelheim Pharmaceuticals extended patients’ survival by more than four months, according to results of a late-stage clinical trial announced Thursday.

December 2, 2010

A growing drug-treated population will cause the Type 2 diabetes drug market in China to increase to $2.5 billion by 2014 ...

November 22, 2010

WOODCLIFF LAKE, N.J. Par Pharmaceutical has begun shipments of a generic treatment for asthma, the drug maker said Monday.

Par announced that it started shipping zafirlukast tablets in the 10-mg and 20-mg strengths. The drug is a generic version of AstraZeneca’s Accolate.

Accolate has sales of $50 million in the United States per year, according to IMS Health.

November 21, 2010

Indian generic drug maker Dr. Reddy’s Labs has launched a version of an asthma drug...

October 27, 2010

Many Type 2 diabetes patients who use the drug Onglyza (saxagliptin) switched to that drug...

October 13, 2010

AstraZeneca is launching a new campaign focused on depression, the Anglo-Swedish drug maker said Thursday....

October 5, 2010

AstraZeneca will provide medications free of charge to qualifying patients in Sacramento, Calif., through its...

September 29, 2010

The Food and Drug Administration has given tentative approval to a generic cholesterol drug made...

September 26, 2010

Supermarket chain Stater Bros. is marking National Breast Cancer Awareness Month in October by giving...

September 23, 2010

An investigational diabetes drug works as well as a generic already on the market, according...

September 22, 2010

The Food and Drug Administration has accepted AstraZeneca’s regulatory application for an investigational cancer drug,...